Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist 
Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk 
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
China vs. NASA: The New Moon Race and What's at Stake by 2030 
Trump Administration Releases New UFO Files and Apollo Mission Records 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Japan Executives Warn Weak Yen and Currency Volatility Threaten Economy 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
South Korean Won Leads Asian FX Losses as Dollar Rises 
S&P 500, Nasdaq Futures Rise as Iran Risks and CPI Loom 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
